FIRALIS Molecular Precision supports academia, biotech and pharmaceutical companies with bioanalytical services (genomics, proteomics, metabolomics) all along the R&D process from new drug target discovery to clinical development. Our objective is to build long-term and strategic partnerships with our collaborators to improve clinical trials success rate by collecting the most insights from each patient's samples. Firalis team has a long-term expertise in biomarker discovery/validation and precision medicine particularly in Neurology, Oncology and Immunology and constantly invest in the latest analytical innovations to offer the best services in the most flexible and customizable way.